Life Science Analytics Market Poised for Strong Growth Through 2035, Driven by AI, Big Data and Precision Medicine Demand
Dublin, Sept. 15, 2026 (GLOBE NEWSWIRE) -- "Life Science Analytics Market Size, Share and Outlook - Growth Analysis Report and Forecast Trends (2026-2035)" has been added to ResearchAndMarkets.com's offering.
The global life science analytics market was valued at USD 39.77 billion in 2025 and is projected to reach USD 120.25 billion by 2035. The market is expected to expand at a compound annual growth rate of 11.70% from 2026 to 2035, supported by advanced analytics adoption, rising healthcare data volumes, expanding clinical trial activity, demand for real-world evidence, and continued digital transformation across the pharmaceutical, biotechnology, and medical device industries.
Key Life Science Analytics Market Insights
Market Growth Drivers
Pharmaceutical and biotechnology companies are increasing investments in analytics platforms to improve drug discovery, clinical development, regulatory planning, supply chain management, and commercial performance. Artificial intelligence, cloud infrastructure, and integrated healthcare data platforms are strengthening decision-making while supporting personalized medicine and real-world evidence initiatives.
Investment in digital health infrastructure is also accelerating life science analytics market growth. In January 2025, Innovaccer secured USD 275 million to expand its platform and advance artificial intelligence capabilities. Investments of this scale support unified analytics environments, improve access to clinical and operational information, and strengthen data-driven strategies across life sciences organizations.
Artificial Intelligence and Cloud Analytics Shape Market Trends
AI-powered data integration is emerging as a significant life science analytics market trend. Companies are prioritizing platforms that connect clinical, research, regulatory, and commercial data while enabling faster analysis and more coordinated workflows. In January 2026, Oracle Corporation launched its Life Sciences AI Data Platform, expanding its capabilities in integrated clinical and research data management. The platform is positioned to enhance operational efficiency and support innovation throughout the life sciences ecosystem.
Cloud-based deployment is expected to remain central to market expansion. The on-demand segment is projected to account for nearly 60% of the delivery market during the forecast period. Scalable infrastructure, real-time analytical capabilities, cost efficiency, and support for distributed research operations are driving adoption over traditional on-premise systems.
Life Science Analytics Market Segmentation
The market is segmented by product into descriptive analytics, predictive analytics, and prescriptive analytics. By end use, the market includes clinical research institutions, pharmaceutical and biotechnology companies, medical device companies, and other organizations.
Application segments include research and development, supply chain analytics, sales and marketing, and other functions. Delivery models comprise on-demand and on-premise solutions. Regional coverage includes North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.
Regional Market Outlook
North America is anticipated to lead the global life science analytics market with an estimated share of approximately 50%. The region benefits from a strong pharmaceutical and biotechnology presence, advanced healthcare infrastructure, early adoption of digital technologies, and substantial investment in artificial intelligence and data analytics. Europe and Asia Pacific are also expected to present growth opportunities as clinical research activity expands and life sciences organizations modernize their data environments.
Leading Life Science Analytics Companies
Accenture PLC (NYSE: ACN) provides consulting, digital, and technology services for clinical data integration, real-world evidence programs, data modernization, and AI-enabled drug development.
Cognizant Technology Solutions Corporation (NASDAQ: CTSH) supports pharmaceutical companies through clinical trial optimization, regulatory compliance services, data management platforms, and digital clinical operations.
IBM Corporation (NYSE: IBM) delivers artificial intelligence, cloud, and data analytics capabilities for drug discovery, clinical research, and pharmaceutical operations, with an emphasis on hybrid cloud environments and research collaboration.
Oracle Corporation (NYSE: ORCL) offers clinical trial management, cloud analytics, healthcare data, and real-world evidence solutions. Its expanding life sciences portfolio supports integrated research workflows and global clinical development.
Additional prominent market participants include IQVIA Inc. (NYSE: IQV), SAS Institute Inc., SAP SE, TAKE Solutions Limited, Scio Health Analytics, and Wipro Limited. Competitive activity includes strategic partnerships, technology collaborations, investments, mergers, acquisitions, and product development initiatives focused on artificial intelligence, cloud computing, and integrated data platforms.
Market Outlook
The life science analytics market is positioned for sustained expansion through 2035 as organizations increase their reliance on advanced analytics throughout the product lifecycle. Continued investment in AI, real-world evidence, cloud delivery, and interoperable data platforms is expected to improve clinical research productivity, strengthen operational performance, and accelerate innovation across the global life sciences industry.
Key Topics Covered:
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Life Science Analytics Market Overview
3.1 Global Life Science Analytics Market Historical Value (2019-2025)
3.2 Global Life Science Analytics Market Forecast Value (2026-2035)
4 Global Life Science Analytics Market Landscape
4.1 Global Life Science Analytics Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Life Science Analytics Product Landscape
4.2.1 Analysis by Product Type
4.2.2 Analysis by Applications
4.2.3 Analysis by End User
5 Global Life Science Analytics Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter's Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Life Science Analytics Market Segmentation
6.1 Global Life Science Analytics Market by Product
6.1.1 Market Overview
6.1.2 Descriptive Analytics
6.1.3 Predictive Analytics
6.1.4 Prescriptive Analytics
6.2 Global Life Science Analytics Market by End Use
6.2.1 Market Overview
6.2.2 Clinical Research Institutes
6.2.3 Pharmaceutical and Biotechnology Companies
6.2.4 Medical Device Companies
6.2.5 Others
6.3 Global Life Science Analytics Market by Application
6.3.1 Market Overview
6.3.2 Research and Development
6.3.3 Supply Chain Analytics
6.3.4 Sales and Marketing
6.3.5 Others
6.4 Global Life Science Analytics Market by Delivery
6.4.1 Market Overview
6.4.2 On-Demand
6.4.3 On-Premise
6.5 Global Life Science Analytics Market by Region
6.5.1 Market Overview
6.5.2 North America
6.5.3 Europe
6.5.4 Asia Pacific
6.5.5 Latin America
6.5.6 Middle East and Africa
7 North America Life Science Analytics Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Life Science Analytics Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Life Science Analytics Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Life Science Analytics Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Life Science Analytics Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
16.1.5 Others
17 Supplier Landscape
17.1 Accenture Plc (NYSE: ACN)
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 Cognizant Technology Solutions Corporation (NASDAQ: CTSH)
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 IBM Corporation (NYSE: IBM)
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Oracle Corporation (NYSE: ORCL)
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 IQVIA Inc. (NYSE: IQV)
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 SAS Institute Inc.
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 WIPRO LIMITED
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 TAKE SOLUTIONS LIMITED
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 SAP SE
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 Scio Health Analytics
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
18 Global Life Science Analytics Market- Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
Companies Featured
For more information about this report visit https://www.researchandmarkets.com/r/8j93ik
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.